• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关疼痛的管理。

Management of cancer-related pain.

机构信息

Department of Emergency Medicine, Beth Israel Medical Center, First Avenue, 16th Street, New York, NY 10003, USA.

出版信息

Hematol Oncol Clin North Am. 2010 Jun;24(3):643-58. doi: 10.1016/j.hoc.2010.03.002.

DOI:10.1016/j.hoc.2010.03.002
PMID:20488359
Abstract

Patients and families struggling with cancer fear pain more than any other physical symptom. There are also significant barriers to optimal pain management in the emergency setting, including lack of knowledge, inexperienced clinicians, myths about addiction, and fears of complications after discharge. In this article, we review the assessment and management options for cancer-related pain based on the World Health Organization (WHO) 3-step approach.

摘要

癌症患者及其家属最害怕的是疼痛,甚于任何其他身体症状。在紧急情况下,疼痛管理也存在很大障碍,包括缺乏知识、临床医生经验不足、对成瘾的误解,以及对出院后并发症的担忧。本文根据世界卫生组织(WHO)三阶梯止痛治疗原则,对癌性疼痛的评估和治疗选择进行综述。

相似文献

1
Management of cancer-related pain.癌症相关疼痛的管理。
Hematol Oncol Clin North Am. 2010 Jun;24(3):643-58. doi: 10.1016/j.hoc.2010.03.002.
2
Management of cancer-related pain.癌症相关疼痛的管理
Emerg Med Clin North Am. 2009 May;27(2):179-94. doi: 10.1016/j.emc.2009.01.002.
3
Concerns about pain management among adolescents with cancer: developing the Adolescent Barriers Questionnaire.对癌症青少年疼痛管理的担忧:编制青少年障碍问卷。
J Pediatr Oncol Nurs. 2006 Jul-Aug;23(4):220-32. doi: 10.1177/1043454206289736.
4
Analysis of patient-related barriers in cancer pain management in Turkish patients.土耳其患者癌症疼痛管理中与患者相关的障碍分析。
J Pain Symptom Manage. 2009 Nov;38(5):727-37. doi: 10.1016/j.jpainsymman.2009.03.004. Epub 2009 Aug 18.
5
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
6
Teaching cancer pain management: durability of educational effects of a role model program.癌症疼痛管理教学:榜样示范项目教育效果的持续性
Cancer. 1996 Mar 1;77(5):996-1001.
7
Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan.关于临终关怀的知识与信念以及专科姑息治疗的效果:日本一项基于人群的调查
J Pain Symptom Manage. 2006 Apr;31(4):306-16. doi: 10.1016/j.jpainsymman.2005.09.004.
8
The knowledge and attitudes of experience oncology nurses regarding the management of cancer-related pain.经验丰富的肿瘤护士对癌症相关疼痛管理的知识和态度。
Oncol Nurs Forum. 1996 Apr;23(3):515-21.
9
The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers.运用风险管理方法保护癌症相关疼痛患者及其医疗服务提供者。
Oncol Nurs Forum. 2008 Nov;35 Suppl:20-4. doi: 10.1188/08.ONF.S1.20-24.
10
The concept of addiction in law and regulatory policy related to pain management: a critical review.法律和监管政策中与疼痛管理相关的成瘾概念:批判性回顾。
Clin J Pain. 2010 Jan;26(1):70-7. doi: 10.1097/AJP.0b013e3181b12a2d.

引用本文的文献

1
Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines.骨癌痛的分子靶点:炎症细胞因子的系统评价。
J Mol Med (Berl). 2024 Sep;102(9):1063-1088. doi: 10.1007/s00109-024-02464-2. Epub 2024 Jun 28.
2
Daily average consumption of 2 long-acting opioids: an interrupted time series analysis.两种长效阿片类药物的每日平均消耗量:一项中断时间序列分析
Am Health Drug Benefits. 2012 Jan;5(1):52-60.
3
Cancer-related neuropathic pain in out-patient oncology clinics: a European survey.门诊肿瘤诊所的癌相关神经性疼痛:一项欧洲调查。
BMC Palliat Care. 2013 Nov 7;12(1):41. doi: 10.1186/1472-684X-12-41.